Moderna stock is falling after a sharp run-up in June that saw shares gain 48%.
July 9 (Reuters) - Moderna said on Thursday it has secured a European Commission contract to supply its respiratory syncytial ...
When a stock and the analysts covering it disagree this sharply, one of them is about to be wrong.
Over 156,000 adults in Europe are hospitalised each year due to RSV, a virus that can cause severe lung issues.
Moderna's growth story is just beginning.
Moderna announced the appointment of Michael McDonnell to its Board of Directors, effective July 8, 2026. He will also join ...
CAMBRIDGE, MA / ACCESS Newswire / July 9, 2026 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live ...
Global health organisation CEPI will give roughly $60 million to Moderna and two other groups to accelerate the development of shots against Ebola Bundibugyo, the deadly virus that has swept through ...
mResvia has been approved in the EU since 2024 to protect adults aged 60 years and older against lower respiratory tract ...
In a Q&A, Kenneth Chien, no longer with Moderna, predicts the company's mRNA cancer vaccine will be transformative for ...
Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are up 14% to $68 and change in afternoon trading Friday, extending a ...
Former Biogen Chief Financial Officer brings more than 35 years of financial leadership and public company experience ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results